National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

levonorgestrel
The levorotatory form of norgestrel and synthetic progestogen with progestational and androgenic activity. Levonorgestrel binds to the progesterone receptor in the nucleus of target cells, thereby stimulating the resulting hormone-receptor complex, initiating transcription, and increasing the synthesis of certain proteins. This results in a suppression of luteinizing hormone (LH) activity and an inhibition of ovulation, as well as an alteration in the cervical mucus and endometrium. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:18-Methylnorethisterone
D-(-)-Norgestrel
US brand names:Norplant
Plan B
Chemical structure names:
  • (17Alpha)-13-ethyl-17-hydroxy-18,19-dinorpregn-4-en-20-yn-3-one
  • 13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one



Previous:levetiracetam, levocarnitine, levodopa, levofloxacin, levonantradol
Next:levonorgestrel-releasing intrauterine system, Levopa, levothyroxine sodium, Levoxyl, Levulan

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov